Ivenix

Ivenix is developing a new infusion platform with the goal of addressing the growing complexity of infusion delivery in the hospital and outpatient healthcare environment. With the increasing burden on our healthcare system to provide high quality care while reducing cost it is imperative that medical device companies develop innovative and intuitive technologies that will help clinicians to provide the best care to their patients.

At Ivenix, we are not only developing an infusion platform, but also the software and information technology that will allow our system to communicate with other information technologies in the healthcare environment. We strive to help improve clinician effectiveness and to allow them to focus on what matters most - their patients.

We are a venture-backed (Fidelity BioSciences, Cardinal Healthcare Partners, SCP Vitalife Partners, and Easterly Capital) start-up based in Amesbury, MA that is targeting the $5B global infusion market.